title: Detection of serum Alu element hypomethylation for the diagnosis and prognosis of glioma.
abstract: Global genomic hypomethylation is a hallmark of cancer in humans. In the present study, the feasibility of measuring hypomethylation of Alu elements (Alu) in serum and its clinical utility were investigated. Tumor tissues and matched serum specimens from 65 glioma patients and serum samples from 30 healthy controls were examined for Alu hypomethylation by bisulfite sequencing. The median serum Alu methylation level was 47.30 % in patients (interquartile range (IQR), 35.40-54.25 %) and 57.90 % in the controls (IQR, 55.25-61.45 %). The median Alu methylation level in tumor samples was 40.30 % (IQR, 36.80-54.20 %), which shows the correlation of Alu hypomethylation between tumor and serum samples (r = 0.882) in the study group. The methylation level was higher in the low-grade glioma group than in the high-grade group both in tumor and serum samples. A correlation between high methylation level and longer survival time was detected in tumor and serum samples. Receiver operating characteristic curve analysis showed that the area under the curve for diagnosis was 0.861 (95 % confidence interval, 0.789-0.933), suggesting that Alu hypomethylation in serum may be of diagnostic value. Our results indicate that the detection of Alu hypomethylation in serum may be clinically useful for the diagnosis and prognosis of glioma.
authors: Department of Neurosurgery, Comprehensive Surgical Laboratory, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, Jiangsu Province, China 226001.
authors: Jian
authors: J
authors: Chen
authors: Mingjie
authors: M
authors: Gong
authors: Shendong
authors: S
authors: Lu
authors: Futian
authors: F
authors: Liu
authors: Liang
authors: L
authors: Xia
authors: Dekang
authors: D
authors: Nie
authors: Feihui
authors: F
authors: Zou
authors: Jinlong
authors: J
authors: Shi
authors: Shaoqing
authors: S
authors: Ju
authors: Longxiang
authors: L
authors: Zhao
authors: Hao
authors: H
authors: Zuo
authors: Jing
authors: J
authors: Qi
authors: Wei
authors: W
authors: Shi
mesh_terms: D000328:Adult; D000368:Aged; D020087:Alu Elements / Q000235:genetics*; D001483:Base Sequence; D001932:Brain Neoplasms / Q000175:diagnosis / Q000235:genetics*; D016022:Case-Control Studies; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000097:blood / Q000737:chemistry*; D005260:Female; D056726:Genetic Association Studies; D005910:Glioma / Q000175:diagnosis / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D011379:Prognosis; D017422:Sequence Analysis, DNA
chemical_list: D004273:DNA, Neoplasm
references: Nucleic Acids Res. 2004 Feb 18;32(3):e38
references: 14973332
references: Oncogene. 2003 Oct 30;22(49):7862-5
references: 14586413
references: Clin Cancer Res. 2007 Apr 15;13(8):2378-84
references: 17438096
references: Nat Rev Cancer. 2004 Feb;4(2):143-53
references: 14732866
references: Nucleic Acids Res. 2005 Dec 02;33(21):6823-36
references: 16326863
references: J Biol Chem. 1987 Jul 25;262(21):9948-51
references: 3611071
references: Ann N Y Acad Sci. 2006 Sep;1075:1-9
references: 17108186
references: J Mol Evol. 1996 Jan;42(1):3-6
references: 8576960
references: Ann N Y Acad Sci. 2006 Sep;1075:299-307
references: 17108224
references: Nature. 2001 Feb 15;409(6822):860-921
references: 11237011
references: Int J Cancer. 2008 Feb 1;122(3):603-8
references: 17943730
references: Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6952-7
references: 20351280
references: Cancer. 2012 Jan 1;118(1):82-90
references: 21713763
references: EMBO J. 1993 Mar;12(3):1141-51
references: 8384552
references: Neuro Oncol. 2010 Feb;12(2):173-80
references: 20150384
references: J Pathol. 2007 Feb;211(3):269-77
references: 17139617
references: Nature. 1998 Sep 3;395(6697):89-93
references: 9738504
references: N Engl J Med. 2000 Nov 9;343(19):1350-4
references: 11070098
references: Clin Cancer Res. 2003 Apr;9(4):1461-8
references: 12684420
references: Int J Cancer. 2011 Jan 1;128(1):33-9
references: 20602342
references: Trends Genet. 2003 Feb;19(2):68-72
references: 12547512
references: Cancer Res. 1977 Mar;37(3):646-50
references: 837366
references: Clin Cancer Res. 2011 Jul 1;17(13):4494-503
references: 21610147
references: J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9
references: 11895036
references: Clin Cancer Res. 2006 Dec 15;12(24):7347-52
references: 17189406
references: J Neurooncol. 2001 Jun;53(2):107-14
references: 11716064
references: Transfusion. 2001 Feb;41(2):276-82
references: 11239235
references: Nucleic Acids Res. 1983 May 25;11(10):3087-95
references: 6856456
references: J Mol Neurosci. 2012 Mar;46(3):470-5
references: 21881830
references: Nature. 2008 Mar 13;452(7184):215-9
references: 18278030
references: Science. 2003 Apr 18;300(5618):455
references: 12702868
references: C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3
references: 18875018
references: Cancer Res. 2006 Sep 1;66(17):8469-76
references: 16951158
references: Adv Cancer Res. 1983;40:1-30
references: 6197868
references: Int J Cancer. 2003 Oct 10;106(6):913-8
references: 12918069
references: Genome Res. 2004 Nov;14(11):2245-52
references: 15520288
references: Nucleic Acids Res. 2008 Feb;36(3):770-84
references: 18084025
references: Clin Biochem. 2013 Jan;46(1-2):64-9
references: 22975639